These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 633636)

  • 1. [Efficacy and limitation of steroid therapy--comparison of polymyositis and myasthenia gravis].
    Nishitani Y; Kurihara J; Tsunematsu T
    Nihon Rinsho; 1978; 36(1):224-8. PubMed ID: 633636
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the syntropy of myasthenia and myositis].
    Körner F; Regli F
    Dtsch Med Wochenschr; 1965 Oct; 90(44):1950-4. PubMed ID: 5833100
    [No Abstract]   [Full Text] [Related]  

  • 3. [Massive prednisolone administration in myasthenia gravis--electrophysiological examination].
    Yanagizawa N; Shoji S; Tsukagoshi H; Toyokura Y
    Nihon Rinsho; 1973 Feb; 31(2):321-6. PubMed ID: 4737112
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenetic therapy of diseases of the nervous system and muscles with large doses of prednisolone on alternate days.
    Gekht BM; Kuzin MI; Kolomenskaya EA; Gnezditskaya EV; Zefirova GS; Ibragimova GV; Ippolitov IK; Kuralesin MG; Polykovskaya ID; Shagal DI
    Neurosci Behav Physiol; 1981; 11(4):363-6. PubMed ID: 7343875
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of a small thymoma associated with myasthenia gravis in which the tumor was reduced by corticosteroid therapy].
    Mizuno T; Hashimoto T; Yamakawa Y; Niwa H; Masaoka A
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Jun; 40(6):975-7. PubMed ID: 1634847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment with prednisolone and tacrolimus for myasthenia gravis with invasive thymoma.
    Miura S; Azuma K; Yamada K; Takamori S; Kawahara A; Noda K; Ayabe M; Kage M; Aizawa H; Taniwaki T
    Acta Neurol Belg; 2010 Mar; 110(1):107-9. PubMed ID: 20514937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis.
    Endo S; Yamaguchi T; Saito N; Otani S; Hasegawa T; Sato Y; Sohara Y
    Ann Thorac Surg; 2004 May; 77(5):1745-50. PubMed ID: 15111178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
    Sekine Y; Kawaguchi N; Hamada C; Sekiguchi H; Yasufuku K; Iyoda A; Shibuya K; Fujisawa T
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):908-13. PubMed ID: 16675232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The syndrome of myasthenia and polymyositis with comments on therapy.
    Johns TR; Crowley WJ; Miller JQ; Campa JF
    Ann N Y Acad Sci; 1971 Sep; 183():64-71. PubMed ID: 5287835
    [No Abstract]   [Full Text] [Related]  

  • 10. Cortactin: a new target in autoimmune myositis and Myasthenia Gravis.
    Berrih-Aknin S
    Autoimmun Rev; 2014 Oct; 13(10):1001-2. PubMed ID: 25182199
    [No Abstract]   [Full Text] [Related]  

  • 11. Eosinophilia, myositis, and myasthenia gravis associated with a thymoma.
    Avni I; Sharabi Y; Sadeh M; Buchman AS
    Muscle Nerve; 2006 Aug; 34(2):242-5. PubMed ID: 16506154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of severe forms of myasthenia with prednisolone and triamcinolone].
    Gekht VM; Kuzin MI; Kuralsein MG; Shagal DI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(6):815-9. PubMed ID: 1217381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Principles and limits of ACTH-cortisone therapy in neurology].
    Bammer HG
    Bibl Psychiatr Neurol; 1969; 139():36-59. PubMed ID: 4332888
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical importance of the electron microscopic study of muscle biopsies in myasthenia during prednisolone therapy].
    Pal'tsev MA; Popova LM
    Arkh Patol; 1981; 43(1):52-8. PubMed ID: 7213083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
    Wakata N; Nemoto H; Sugimoto H; Nomoto N; Konno S; Hayashi N; Araki Y; Nakazato A
    Clin Neurol Neurosurg; 2004 Mar; 106(2):139-41. PubMed ID: 15003307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid responsive fibrosing alveolitis in myasthenia gravis.
    Knox AJ; Bowker AM; Sumner DW; Muers MF
    Eur J Respir Dis; 1987 Aug; 71(2):132-4. PubMed ID: 3622664
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long term administration of oral prednisone or prednisolone in treatment of myasthenia gravis. Report of five cases (author's transl)].
    Contamin F; Singer B; Mignot B; Offenstadt G; Ecoffet M
    Sem Hop; 1978 Nov 18-25; 54(41-42):1213-8. PubMed ID: 216096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients.
    Luther C; Adamopoulou E; Stoeckle C; Brucklacher-Waldert V; Rosenkranz D; Stoltze L; Lauer S; Poeschel S; Melms A; Tolosa E
    J Immunol; 2009 Jul; 183(2):841-8. PubMed ID: 19542375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year follow-up with low-dose tacrolimus in patients with myasthenia gravis.
    Minami N; Fujiki N; Doi S; Shima K; Niino M; Kikuchi S; Sasaki H
    J Neurol Sci; 2011 Jan; 300(1-2):59-62. PubMed ID: 21035148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term therapeutic efficacy and safety of low-dose tacrolimus (FK506) for myasthenia gravis.
    Tada M; Shimohata T; Tada M; Oyake M; Igarashi S; Onodera O; Naruse S; Tanaka K; Tsuji S; Nishizawa M
    J Neurol Sci; 2006 Aug; 247(1):17-20. PubMed ID: 16631797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.